Park Square has placed Mark Namchuk, Ph.D. as executive director of therapeutics translation at Harvard Medical School.
This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.
Park Square has placed Jeffrey Goldberg as Chief Executive Officer and Director of Immunitas Therapeutics.
Wilkes University’s Board of Trustees announced that Greg Cant, Ph.D. will be the University’s seventh president. Cant, currently serving...